SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 4, 2005
MILESTONE SCIENTIFIC INC.
(Exact name of Registrant as specified in its charter)
Delaware 0-26284 13-3545623
(State or other jurisdiction of (Commission (IRS Employer Identification
incorporation) File Number) No.)
220 South Orange Avenue, Livingston Corporate Park, Livingston, New Jersey 07034
(Address of principal executive office) (Zip Code)
Registrant's telephone number, including area code (973) 535-2717
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing
On January 5, 2005, Milestone Scientific Inc. ("Milestone") issued a press
release disclosing that on January 4, 2005 Milestone had received notice from
the American Stock Exchange ("AMEX") that it is not in compliance with AMEX's
continued listing standards related to shareholders' equity and losses as
specified in Section 1003(a)(iii) of the AMEX Company Guide, which requires
Milestone to have shareholder equity of $6,000,000. At September 30, 2004
Milestone's reported shareholder equity was $5,008,448. Milestone plans to
submit to AMEX, by January 14, 2005, a plan advising AMEX of action it will take
to bring it into compliance with the continued listing standards. A copy of the
press release is attached as Exhibit 99.1.
Item 9.01: Financial Statements and Exhibits
(c) Exhibits:
99.1 Press Release dated January 5, 2005
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Current Report on Form 8-K to be signed on its
behalf by the undersigned, hereunto duly authorized.
MILESTONE SCIENTIFIC INC.
By: /s/ Leonard Osser
------------------------------------
Leonard Osser
Chairman and Chief Executive Officer
Dated: January 5, 2005